Literature DB >> 14982998

Crystal structure of a benzo[a]pyrene diol epoxide adduct in a ternary complex with a DNA polymerase.

Hong Ling1, Jane M Sayer, Brian S Plosky, Haruhiko Yagi, François Boudsocq, Roger Woodgate, Donald M Jerina, Wei Yang.   

Abstract

The first occupation-associated cancers to be recognized were the sooty warts (cancers of the scrotum) suffered by chimney sweeps in 18th century England. In the 19th century, high incidences of skin cancers were noted among fuel industry workers. By the early 20th century, malignant skin tumors were produced in laboratory animals by repeatedly painting them with coal tar. The culprit in coal tar that induces cancer was finally isolated in 1933 and determined to be benzo[a]pyrene (BP), a polycyclic aromatic hydrocarbon. A residue of fuel and tobacco combustion and frequently ingested by humans, BP is metabolized in mammals to benzo[a]pyrene diol epoxide (BPDE), which forms covalent DNA adducts and induces tumor growth. In the 70 yr since its isolation, BP has been the most studied carcinogen. Yet, there has been no crystal structure of a BPDE DNA adduct. We report here the crystal structure of a BPDE-adenine adduct base-paired with thymine at a template-primer junction and complexed with the lesion-bypass DNA polymerase Dpo4 and an incoming nucleotide. Two conformations of the BPDE, one intercalated between base pairs and another solvent-exposed in the major groove, are observed. The latter conformation, which can be stabilized by organic solvents that reduce the dielectric constant, seems more favorable for DNA replication by Dpo4. These structures also suggest a mechanism by which mutations are generated during replication of DNA containing BPDE adducts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982998      PMCID: PMC356939          DOI: 10.1073/pnas.0308332100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Crystal structure of a Y-family DNA polymerase in action: a mechanism for error-prone and lesion-bypass replication.

Authors:  H Ling; F Boudsocq; R Woodgate; W Yang
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  Crystal structure of a DinB lesion bypass DNA polymerase catalytic fragment reveals a classic polymerase catalytic domain.

Authors:  B L Zhou; J D Pata; T A Steitz
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

3.  The mutational specificity of the Dbh lesion bypass polymerase and its implications.

Authors:  Olga Potapova; Nigel D F Grindley; Catherine M Joyce
Journal:  J Biol Chem       Date:  2002-05-21       Impact factor: 5.157

Review 4.  Specialized DNA polymerases, cellular survival, and the genesis of mutations.

Authors:  Errol C Friedberg; Robert Wagner; Miroslav Radman
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

5.  Translesion replication of benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase iota.

Authors:  Ekaterina G Frank; Jane M Sayer; Heiko Kroth; Eiji Ohashi; Haruo Ohmori; Donald M Jerina; Roger Woodgate
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

6.  Preferential misincorporation of purine nucleotides by human DNA polymerase eta opposite benzo[a]pyrene 7,8-diol 9,10-epoxide deoxyguanosine adducts.

Authors:  Dominic Chiapperino; Heiko Kroth; Irene H Kramarczuk; Jane M Sayer; Chikahide Masutani; Fumio Hanaoka; Donald M Jerina; Albert M Cheh
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

7.  Polkappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene.

Authors:  Tomoo Ogi; Yoichi Shinkai; Kiyoji Tanaka; Haruo Ohmori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

8.  Translesion synthesis by human DNA polymerase kappa on a DNA template containing a single stereoisomer of dG-(+)- or dG-(-)-anti-N(2)-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene).

Authors:  Naomi Suzuki; Eiji Ohashi; Alexander Kolbanovskiy; Nicholas E Geacintov; Arthur P Grollman; Haruo Ohmori; Shinya Shibutani
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

9.  Solution structure of a cis-opened (10R)-N6-deoxyadenosine adduct of (9S,10R)-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA duplex.

Authors:  David E Volk; Varatharasa Thiviyanathan; Jeffrey S Rice; Bruce A Luxon; Jamshed H Shah; Haruhiko Yagi; Jane M Sayer; Herman J C Yeh; Donald M Jerina; David G Gorenstein
Journal:  Biochemistry       Date:  2003-02-18       Impact factor: 3.162

10.  trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases.

Authors:  Olga Rechkoblit; Yanbin Zhang; Dongyu Guo; Zhigang Wang; Shantu Amin; Jacek Krzeminsky; Natalia Louneva; Nicholas E Geacintov
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

View more
  65 in total

1.  Identification of an unfolding intermediate for a DNA lesion bypass polymerase.

Authors:  Shanen M Sherrer; Brian A Maxwell; Lindsey R Pack; Kevin A Fiala; Jason D Fowler; Jun Zhang; Zucai Suo
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  Translesion synthesis past the C8- and N2-deoxyguanosine adducts of the dietary mutagen 2-Amino-3-methylimidazo[4,5-f]quinoline in the NarI recognition sequence by prokaryotic DNA polymerases.

Authors:  James S Stover; Goutam Chowdhury; Hong Zang; F Peter Guengerich; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

3.  Site specific synthesis and polymerase bypass of oligonucleotides containing a 6-hydroxy-3,5,6,7-tetrahydro-9H-imidazo[1,2-a]purin-9-one base, an intermediate in the formation of 1,N2-etheno-2'-deoxyguanosine.

Authors:  Angela K Goodenough; Ivan D Kozekov; Hong Zang; Jeong-Yun Choi; F Peter Guengerich; Thomas M Harris; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2005-11       Impact factor: 3.739

4.  Subtle but variable conformational rearrangements in the replication cycle of Sulfolobus solfataricus P2 DNA polymerase IV (Dpo4) may accommodate lesion bypass.

Authors:  Yanli Wang; Karunesh Arora; Tamar Schlick
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

5.  Mechanism of template-independent nucleotide incorporation catalyzed by a template-dependent DNA polymerase.

Authors:  Kevin A Fiala; Jessica A Brown; Hong Ling; Ajay K Kshetry; Jun Zhang; John-Stephen Taylor; Wei Yang; Zucai Suo
Journal:  J Mol Biol       Date:  2006-10-07       Impact factor: 5.469

6.  Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis.

Authors:  Alexandra Vaisman; Hong Ling; Roger Woodgate; Wei Yang
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

7.  Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features.

Authors:  Vinod K Batra; David D Shock; Rajendra Prasad; William A Beard; Esther W Hou; Lars C Pedersen; Jane M Sayer; Haruhiko Yagi; Subodh Kumar; Donald M Jerina; Samuel H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

8.  Amino acid architecture that influences dNTP insertion efficiency in Y-family DNA polymerase V of E. coli.

Authors:  Kwang Young Seo; Jun Yin; Prashant Donthamsetti; Sushil Chandani; Chui Hong Lee; Edward L Loechler
Journal:  J Mol Biol       Date:  2009-07-14       Impact factor: 5.469

9.  Conformational changes during nucleotide selection by Sulfolobus solfataricus DNA polymerase Dpo4.

Authors:  Robert L Eoff; Raymundo Sanchez-Ponce; F Peter Guengerich
Journal:  J Biol Chem       Date:  2009-06-10       Impact factor: 5.157

10.  Impact of conformational heterogeneity of OxoG lesions and their pairing partners on bypass fidelity by Y family polymerases.

Authors:  Olga Rechkoblit; Lucy Malinina; Yuan Cheng; Nicholas E Geacintov; Suse Broyde; Dinshaw J Patel
Journal:  Structure       Date:  2009-05-13       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.